Table 1.
Characteristic | n = 74 |
---|---|
Age, median (IQR), year | 6.1 (1.7–3.9) |
Male gender, n (%) | 35 (47%) |
Prior Comorbidity, n (%) | 36 (49%) |
Oncologic/Immunocompromised, n (%) | 11 (14.9%) |
Initial lactate, median (IQR), mmol/L | 2.5 (1.5–4.4) |
PRISM-III a, median (IQR) | 9 (3–14) |
Day 1 PELOD a, median (IQR) | 11 (10–20) |
Vasoactive use, n (%) | 38 (51%) |
Mechanical ventilation, n (%) | 36 (49%) |
Shock, n (%) | 3 (4%) |
Mortality, n (%) | 12 (16%) |
PICU LOS a, median (IQR), days | 4 (2–12) |
Hospital LOS a, median (IQR), days | 10 (5–22) |
Abbreviations: PRISM-III = pediatric risk of mortality score; PELOD = pediatric logistic organ dysfunction score; LOS = length of stay